It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
Best Prices:
from
1.66 €/AA
High-quality peptides at competitive prices are just one click away! Starting at €1.66 per amino acid, you can generate synthetic peptides up to 150 residues with an unlimited range of modifications and pay only if you’re satisfied with your order. In just a few clicks, fill out the form to receive an instant quote and order directly from our shop using the secure online payment system. Start your custom peptide synthesis now!
The most competitive price for peptide synthesis on the market.
We guarantee to provide you with the most competitive price.
Save time and buy your peptides thanks to our online form. Delivery in 10 business days.
ProteoGenix can synthesize peptides up to 150 AA.
ProteoGenix offers an unlimited range of peptide modifications.
Your project is our priority so we will start from the beginning until we get the right peptide or you won’t pay a thing.
| Peptide synthesis method |
|
| Quantity |
|
| Purity |
|
| Lead time |
|
| Shipping |
|
| Peptide order |
|
| Standard QC report |
|
| Additional analysis (upon request) |
|
| Solubility test (upon request) |
|
At ProteoGenix, we offer recombinant expression and semisynthesis
(ligation of synthetic and recombinant fragments) in addition to the
standard Fmoc solid-phase synthesis. If you are working with complex
structures, reach out to our team to learn how we can help.
If you are looking for an expert’s advice to help you maximize the stability and yield of your synthetic peptide while keeping production costs low, reach out to our team for more information.
The most commonly used method to test solubility is based on charge determination. For small peptides with up to 5 amino-acids, distilled water remains the first option. For other cases, you can refer to this guide:
Attribute -1 to each acidic residue (Asp / D, Glu / E) and to the terminal carboxylic acid.
Then, assign +1 to each basic residues (Arg / R, Lys / K, His/h) and the terminal amine.
Sum up both values to determine the overall charge of your peptide
If the overall charge value is positive, try to dissolve your peptide in water.
In case the peptide does not dissolve, acidify your solution with an acetic acid solution (10 to 30%).
Add TFA if acetic acid does not allow peptide dilution du sufficient concentration
In case the overall charge is negative and the peptide does not contain cysteine residues, try to dissolve your peptide in water.
If the peptide does not dissolve, add ammonium hydroxide to obtain the desired concentration.
If the overall calculated charge is zero, the peptide can be diluted with organic solvents (methanol, ethanol, isopropanol or acetonitrile).
A small amount of DMSO diluted with water can be used depending on final application.
Specific care is requested for peptide containing cysteine, methionine or tryptophan residues as they are sensitive to oxidation.
In these cases, replace DMSO by DMF.
Synthetic antigenic peptides represent powerful tools for polyclonal or monoclonal antibody generation and as components of peptide vaccines. For these applications, peptides need to be designed with two properties in mind: antigenicity and immunogenicity.The first term is used to describe the ability of an antigen to interact with an antibody’s functional binding site, while the second term describes a peptide’s ability to elicit a humoral an/or cellular immune response. For effective vaccine and antibody production, peptides must have both properties.
Choosing hydrophilic sequences : soluble regions have surface-exposed hydrophilic residues, more likely to elicit an immune response.
Ensuring high epitope accessibility : steric hindrance can hamper antibody-antigen interaction even in hydrophilic regions, it is essential to ensure the epitope can be easily accessed in the native protein.
Opting for an optimal peptide length : to maximize antigenicity, peptides should have between 10 and 20 AA residues. Short peptides (<10 AA) are unlikely to be bound by antibodies, while long peptides (>20 AA) are likely to adopt three-dimensional conformations that do not accurately mimic the structure of the native protein.
Peptide orientation : the peptide should always be presented in a similar manner than it would be presented in the native protein.
Nature of the carrier protein : the carrier protein often contains several epitopes able to elicit an immune response, thus, choosing the right carrier is of utmost importance to ensure the. KLH and BSA are the most used carrier proteins. KLH is the preferred molecule because of its large mass and complexity which elicit a much stronger immune response.
Many peptide drugs are generated by chemical modification of natural molecules. These drugs remain invaluable for the treatment of multiple metabolic diseases.
Vaccines are considered one of the most successful strategies of modern medicine. Conventional vaccines have relied heavily in inactive pathogens to elicit an immune response, making them hard to produce. In contrast, peptide vaccines are increasingly considered as a cost-effective, safer, and highly specific alternative.
The discovery of cell adhesion and self-assembling peptides has opened up a new window of opportunity in tissue engineering applications. These peptides are increasingly used as bioactive molecules to support cellular growth and tissue regeneration.
Cell-penetrating peptides and self-assembling peptides are two increasingly important bioactive components of advanced gene and drug delivery applications . In comparison to conventional methods that make use of viral vectors, peptides are much easier to synthesize, thus, helping make the technology more accessible and widespread.
Many personal care products harness the beneficial properties of cosmetic peptides . Small peptides able to cross the skin barrier are often incorporated in cosmetics due to their easy diffusion allied to their protective and regenerative properties. Peptides with antimicrobial properties are also often incorporated in creams to prevent and treat several well-known skin conditions.
| Chemical synthesis | Recombinant expression | Semisynthesis |
|---|---|---|
|
|
Combination of synthetic and recombinant fragments via chemical or enzymatic ligation |
Solid-phase peptide synthesis has dominated custom production for decades. Developed in the 1950s, the method remains unmatched for automation, cost-effectiveness, scalability, lead times, and yields. It is carried out stepwise on a solid support, from the C to the N terminus, using Nα-protected amino acids to minimize side reactions.
Removed using TFA during deprotection.
Removed using piperidine during deprotection.
Permanent side-chain protection groups, most commonly Benzyl (Bzl) and tert-butyl (tBu), prevent unwanted branching and withstand repeated chemical treatment, and are only removed at the final stage using strong acids.
Nα-protective groups need to be removed to allow the addition of a new residue at the N-terminus. Deprotection agents used in this step depend on the nature of the protective groups. In this way, TFA (trifluoracetic acid) is used for Boc and piperidine for Fmoc-protected amino acids.
2. Coupling :
The addition of a new amino acid residue at the N-terminus of a polypeptide chain requires the activation of the C-terminal carboxylic acid. Carbodiimides such as dicyclohexylcarbodiimide (DCC) or diisopropylcarbodiimide (DIC) are widely used coupling reagents.
3. Cleavage :
After several cycles of deprotection and coupling, all remaining protective groups need to be cleaved from the new polypeptide chain.
Strong acids such as hydrogen fluoride (HF), hydrogen bromide (HBr) or trifluoromethane sulfonic acid (TFMSA) are used to cleave Boc and Bzl groups, while a relatively milder acid such as TFA is sufficient to cleave Fmoc and tBut groups.
During this stage, the peptide chain is also separated from the solid support in order to be further purified.
When to look beyond solid-phase :
The strong chemicals used in solid-phase synthesis can complicate purification. Liquid-phase synthesis is often used instead for GMP-grade production, though it remains mainly limited to short, highly pure peptides (<10 AA).
Both are chemical methods best suited to linear peptides. For large peptides with complex structures, recombinant expression is a better option — but it’s restricted to natural amino acids. When unnatural amino acids and complex structures are both required, a semisynthetic approach is often the ideal solution.
Despite the high efficiency of most peptide synthesis methods, many of these processes may still generate undesired impurities due to incomplete deprotection, unwanted reactions between free protecting groups, truncation and/or deletion of amino acids, isomers, and other side products.
Removal of these impurities is recurrently achieved by using one or several purification techniques:
Among these, RP-HPLC is the most widely used process of purification. Unlike conventional HPLC that separates products according to the concentration of polar solvents on the mobile phase, RP-HPLC captures hydrophobic molecules from aqueous solutions and releases them in function of their hydrophobicity. This makes it easier to separate correctly synthesized peptides from undesired impurities.
